Janssen\'s Imbruvica shows superiority in Phase 3 trials httpbit.ly2IgxOVUÂ pharma oncologypic.twitter.comxUX8tAs0NM

Janssen's Imbruvica shows superiority in Phase 3 trials http://bit.ly/2IgxOVU  #pharma #oncologypic.twitter.com/xUX8tAs0NM

07:31 EDT 4 Jun 2019 | Pharmafile

Janssen's Imbruvica shows superiority in Phase 3 trials http://bit.ly/2IgxOVU  #pharma #oncology pic.twitter.com/xUX8tAs0NM

More From BioPortfolio on "Janssen's Imbruvica shows superiority in Phase 3 trials http://bit.ly/2IgxOVU  #pharma #oncologypic.twitter.com/xUX8tAs0NM"